370.85
price up icon0.35%   1.29
after-market After Hours: 370.85
loading
United Therapeutics Corp stock is traded at $370.85, with a volume of 317.23K. It is up +0.35% in the last 24 hours and up +3.03% over the past month. United Therapeutics specializes in drug development for pulmonary arterial hypertension, a rare and progressive disease marked by abnormally high blood pressure in the arteries of the lungs. The company's therapies for PAH largely focus on the prostacyclin pathway, and many of its treatments are based on the same molecule, treprostinil. Most of the company's sales are generated within the United States. United Therapeutics also markets a pediatric oncology drug, but its focus largely remains in pulmonary arterial hypertension.
See More
Previous Close:
$369.56
Open:
$370.99
24h Volume:
317.23K
Relative Volume:
1.04
Market Cap:
$16.56B
Revenue:
$2.76B
Net Income/Loss:
$1.11B
P/E Ratio:
16.29
EPS:
22.77
Net Cash Flow:
$898.10M
1W Performance:
+0.78%
1M Performance:
+3.03%
6M Performance:
+9.65%
1Y Performance:
+70.11%
1-Day Range:
Value
$368.02
$382.61
1-Week Range:
Value
$365.88
$382.61
52-Week Range:
Value
$208.62
$417.81

United Therapeutics Corp Stock (UTHR) Company Profile

Name
Name
United Therapeutics Corp
Name
Phone
(301) 608-9292
Name
Address
1000 SPRING ST, SILVER SPRING, MD
Name
Employee
1,168
Name
Twitter
Name
Next Earnings Date
2024-10-30
Name
Latest SEC Filings
Name
UTHR's Discussions on Twitter

Compare UTHR with other stocks

Stocks Price Market Cap Revenue Net Income Cash Flow EPS
Biotechnology icon
UTHR
United Therapeutics Corp
370.85 16.56B 2.76B 1.11B 898.10M 22.77
Biotechnology icon
VRTX
Vertex Pharmaceuticals Inc
440.68 113.49B 10.63B -479.80M -1.35B -1.99
Biotechnology icon
REGN
Regeneron Pharmaceuticals Inc
686.33 75.42B 13.85B 4.65B 3.32B 40.41
Biotechnology icon
ARGX
Argen X Se Adr
648.11 39.38B 1.86B -40.29M -1.28B -0.85
Biotechnology icon
ALNY
Alnylam Pharmaceuticals Inc
279.19 36.01B 2.09B -332.26M 16.06M -2.62
Biotechnology icon
BNTX
Biontech Se Adr
124.30 29.80B 3.30B -501.07M 1.03B -2.1146

United Therapeutics Corp Stock (UTHR) Upgrades & Downgrades

Date Action Analyst Rating Change
Jul-11-24 Downgrade Morgan Stanley Overweight → Equal-Weight
Feb-12-24 Upgrade Goldman Sell → Neutral
Feb-05-24 Initiated Leerink Partners Outperform
Dec-08-23 Initiated Wells Fargo Overweight
Dec-06-22 Initiated UBS Buy
Dec-05-22 Initiated Goldman Sell
Oct-11-22 Initiated Morgan Stanley Overweight
Sep-20-22 Reiterated BofA Securities Underperform
Sep-19-22 Resumed Wedbush Outperform
Feb-11-22 Initiated BTIG Research Neutral
Jul-14-21 Upgrade Argus Hold → Buy
Apr-26-21 Resumed Credit Suisse Outperform
Feb-01-21 Upgrade H.C. Wainwright Neutral → Buy
Sep-14-20 Resumed JP Morgan Overweight
Jun-25-20 Reiterated H.C. Wainwright Neutral
Mar-10-20 Upgrade Jefferies Hold → Buy
Feb-27-20 Upgrade Cowen Market Perform → Outperform
Jan-31-20 Upgrade JP Morgan Neutral → Overweight
Dec-03-19 Initiated BofA/Merrill Underperform
Aug-01-19 Upgrade Jefferies Underperform → Hold
Aug-01-19 Upgrade Ladenburg Thalmann Neutral → Buy
Jul-01-19 Upgrade Credit Suisse Neutral → Outperform
May-17-19 Upgrade UBS Sell → Neutral
May-09-19 Upgrade Credit Suisse Underperform → Neutral
Oct-12-18 Upgrade Standpoint Research Hold → Buy
Aug-08-18 Downgrade Credit Suisse Neutral → Underperform
Apr-03-18 Upgrade Credit Suisse Underperform → Neutral
Feb-22-18 Reiterated Barclays Underweight
Jan-18-18 Resumed Credit Suisse Underperform
Dec-27-17 Reiterated Wedbush Outperform
Apr-27-17 Reiterated Wedbush Outperform
Mar-30-17 Initiated UBS Sell
Mar-16-17 Initiated Credit Suisse Underperform
View All

United Therapeutics Corp Stock (UTHR) Latest News

pulisher
04:36 AM

United Therapeutics president sells shares worth $3.7 million - Investing.com

04:36 AM
pulisher
12:54 PM

KBC Group NV Has $43.42 Million Stock Position in United Therapeutics Co. (NASDAQ:UTHR) - MarketBeat

12:54 PM
pulisher
Jan 27, 2025

Pacer Advisors Inc. Buys 30,931 Shares of United Therapeutics Co. (NASDAQ:UTHR) - MarketBeat

Jan 27, 2025
pulisher
Jan 24, 2025

Veracity Capital LLC Purchases 1,446 Shares of United Therapeutics Co. (NASDAQ:UTHR) - MarketBeat

Jan 24, 2025
pulisher
Jan 24, 2025

Nisa Investment Advisors LLC Boosts Holdings in United Therapeutics Co. (NASDAQ:UTHR) - MarketBeat

Jan 24, 2025
pulisher
Jan 24, 2025

HB Wealth Management LLC Purchases Shares of 1,066 United Therapeutics Co. (NASDAQ:UTHR) - MarketBeat

Jan 24, 2025
pulisher
Jan 24, 2025

United Therapeutics Co. (NASDAQ:UTHR) Receives Consensus Rating of "Moderate Buy" from Brokerages - MarketBeat

Jan 24, 2025
pulisher
Jan 23, 2025

United Therapeutics plans $96M facility for genetically edited swine in northeast Houston - The Business Journals

Jan 23, 2025
pulisher
Jan 23, 2025

United Therapeutics president Michael Benkowitz sells shares worth $3.65m - MSN

Jan 23, 2025
pulisher
Jan 22, 2025

United Therapeutics president Michael Benkowitz sells shares worth $3.65m By Investing.com - Investing.com Canada

Jan 22, 2025
pulisher
Jan 22, 2025

Merit Financial Group LLC Has $1.22 Million Stock Holdings in United Therapeutics Co. (NASDAQ:UTHR) - MarketBeat

Jan 22, 2025
pulisher
Jan 22, 2025

United Therapeutics Co. (NASDAQ:UTHR) Shares Purchased by Park Avenue Securities LLC - Defense World

Jan 22, 2025
pulisher
Jan 21, 2025

United Therapeutics to Present Groundbreaking Tyvaso DPI Data at PVRI 2025 Congress - StockTitan

Jan 21, 2025
pulisher
Jan 18, 2025

Manchester gets offer from United Therapeutics to buy nearly 350 acres in Hackett Hill area - AOL

Jan 18, 2025
pulisher
Jan 18, 2025

United Therapeutics Corporation (NASDAQ:UTHR) Doing What It Can To Lift Shares - Simply Wall St

Jan 18, 2025
pulisher
Jan 18, 2025

Wedge Capital Management L L P NC Has $28.03 Million Position in United Therapeutics Co. (NASDAQ:UTHR) - MarketBeat

Jan 18, 2025
pulisher
Jan 18, 2025

Assenagon Asset Management S.A. Sells 8,067 Shares of United Therapeutics Co. (NASDAQ:UTHR) - MarketBeat

Jan 18, 2025
pulisher
Jan 17, 2025

USA Financial Formulas Has $307,000 Stake in United Therapeutics Co. (NASDAQ:UTHR) - MarketBeat

Jan 17, 2025
pulisher
Jan 16, 2025

United Therapeutics (NASDAQ:UTHR) Raised to Strong-Buy at StockNews.com - MarketBeat

Jan 16, 2025
pulisher
Jan 16, 2025

United Therapeutics Co. (NASDAQ:UTHR) Short Interest Update - MarketBeat

Jan 16, 2025
pulisher
Jan 16, 2025

Wedmont Private Capital Acquires Shares of 1,276 United Therapeutics Co. (NASDAQ:UTHR) - MarketBeat

Jan 16, 2025
pulisher
Jan 15, 2025

UTHR: 3 Niche Biotech Stocks Redefining Innovation - StockNews.com

Jan 15, 2025
pulisher
Jan 15, 2025

Burney Co. Raises Stock Holdings in United Therapeutics Co. (NASDAQ:UTHR) - MarketBeat

Jan 15, 2025
pulisher
Jan 15, 2025

United Therapeutics (NASDAQ:UTHR) to Provide Business Update at J.P. Morgan Healthcare Conference - Defense World

Jan 15, 2025
pulisher
Jan 14, 2025

United Therapeutics Co. (NASDAQ:UTHR) COO Sells $3,646,200.00 in Stock - MarketBeat

Jan 14, 2025
pulisher
Jan 14, 2025

United Therapeutics president sells $3.65 million in stock By Investing.com - Investing.com Australia

Jan 14, 2025
pulisher
Jan 14, 2025

United Therapeutics president sells $3.65 million in stock - Investing.com India

Jan 14, 2025
pulisher
Jan 14, 2025

Evolving Landscape of Cardiology Segment: Key Market Insights of Latest Published Rare Cardiovascular Diseases Report — Giant-Cell Arteritis, Pulmonary Arterial Hypertension, and Restrictive Cardiomyopathy | DelveInsight - GlobeNewswire Inc.

Jan 14, 2025
pulisher
Jan 13, 2025

United Therapeutics to Present at J.P. Morgan Conference - TipRanks

Jan 13, 2025
pulisher
Jan 13, 2025

Nordea Investment Management AB Sells 75,464 Shares of United Therapeutics Co. (NASDAQ:UTHR) - Defense World

Jan 13, 2025
pulisher
Jan 13, 2025

United Therapeutics Co. (NASDAQ:UTHR) Shares Sold by Nordea Investment Management AB - MarketBeat

Jan 13, 2025
pulisher
Jan 10, 2025

Here's Why United Therapeutics (UTHR) is a Strong Growth Stock - Yahoo Finance

Jan 10, 2025
pulisher
Jan 10, 2025

UBS Group Boosts United Therapeutics (NASDAQ:UTHR) Price Target to $475.00 - Defense World

Jan 10, 2025
pulisher
Jan 09, 2025

Here's Why United Therapeutics (UTHR) is a Strong Value Stock - Yahoo Finance

Jan 09, 2025
pulisher
Jan 09, 2025

Are Medical Stocks Lagging United Therapeutics (UTHR) This Year? - Yahoo Finance

Jan 09, 2025
pulisher
Jan 08, 2025

7 Best Biotech Stocks to Buy for 2025 | Investing - U.S News & World Report Money

Jan 08, 2025
pulisher
Jan 08, 2025

United Therapeutics president Michael Benkowitz sells $3.55 million in stock By Investing.com - Investing.com Australia

Jan 08, 2025
pulisher
Jan 08, 2025

United Therapeutics president Michael Benkowitz sells $3.55 million in stock - Investing.com India

Jan 08, 2025
pulisher
Jan 07, 2025

United Therapeutics snaps up another property near Silver Spring HQ - The Business Journals

Jan 07, 2025
pulisher
Jan 07, 2025

CWA Asset Management Group LLC Makes New Investment in United Therapeutics Co. (NASDAQ:UTHR) - MarketBeat

Jan 07, 2025
pulisher
Jan 06, 2025

United Therapeutics CEO to Present Business Update at J.P. Morgan Healthcare Conference - StockTitan

Jan 06, 2025
pulisher
Jan 04, 2025

JPMorgan Chase & Co. Has $69 Million Stock Holdings in United Therapeutics Co. (NASDAQ:UTHR) - MarketBeat

Jan 04, 2025
pulisher
Jan 01, 2025

Insider Sell: Nilda Mesa Sells Shares of United Therapeutics Cor - GuruFocus.com

Jan 01, 2025
pulisher
Dec 31, 2024

Nilda Mesa Sells 255 Shares of United Therapeutics Co. (NASDAQ:UTHR) Stock - MarketBeat

Dec 31, 2024
pulisher
Dec 31, 2024

United Therapeutics president Michael Benkowitz sells $3.57 million in stock By Investing.com - Investing.com Canada

Dec 31, 2024
pulisher
Dec 31, 2024

United Therapeutics director Mesa Nilda sells $90,720 in stock By Investing.com - Investing.com Nigeria

Dec 31, 2024
pulisher
Dec 31, 2024

United Therapeutics director Mesa Nilda sells $90,720 in stock - Investing.com India

Dec 31, 2024
pulisher
Dec 31, 2024

United Therapeutics president Michael Benkowitz sells $3.57 million in stock - Investing.com

Dec 31, 2024
pulisher
Dec 30, 2024

Stewartville awarded $1 million state grant for planned pig-to-human transplant center - Star Tribune

Dec 30, 2024
pulisher
Dec 29, 2024

We Ran A Stock Scan For Earnings Growth And United Therapeutics (NASDAQ:UTHR) Passed With Ease - Yahoo Finance

Dec 29, 2024

United Therapeutics Corp Stock (UTHR) Financials Data

Revenue

loading

Net Income

loading

Cash Flow

loading

EPS

loading
$4.91
price up icon 5.14%
$44.94
price up icon 7.90%
$23.50
price down icon 0.09%
biotechnology ONC
$226.67
price up icon 0.63%
$124.30
price up icon 3.80%
Cap:     |  Volume (24h):